Search for Clinical Trial Results
Adenocarcinoma of the Appendix - 170 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers Condition: Advanced GI Cancer Date: 2014-10-15 Interventions: Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14 |
Active, not recruiting |
Study Name: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Condition:
|
Withdrawn |
Study Name: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer Condition:
|
Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition:
|
Terminated |
Study Name: Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery Condition:
|
Withdrawn |
Study Name: Research Study in Patients With Advanced Ovarian Epithelial Cancer Condition:
|
Active, not recruiting |
Study Name: Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Condition:
Interventions: |
Terminated |
Study Name: Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer Condition:
|
Completed |
Study Name: Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer Condition:
Interventions: |